nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—P2RY12—blood plasma—hepatitis B	0.0401	0.321	CbGeAlD
Epoprostenol—Ascites—Entecavir—hepatitis B	0.0283	0.0386	CcSEcCtD
Epoprostenol—PTGIR—blood plasma—hepatitis B	0.0256	0.205	CbGeAlD
Epoprostenol—Platelet count decreased—Entecavir—hepatitis B	0.0216	0.0295	CcSEcCtD
Epoprostenol—Splenomegaly—Lamivudine—hepatitis B	0.0215	0.0293	CcSEcCtD
Epoprostenol—PTGIS—Eicosanoid Synthesis—GGT2—hepatitis B	0.0195	0.138	CbGpPWpGaD
Epoprostenol—Influenza-like symptoms—Telbivudine—hepatitis B	0.0148	0.0202	CcSEcCtD
Epoprostenol—P2RY12—blood—hepatitis B	0.0147	0.118	CbGeAlD
Epoprostenol—PTGIS—liver—hepatitis B	0.0128	0.102	CbGeAlD
Epoprostenol—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0123	0.0168	CcSEcCtD
Epoprostenol—Chest discomfort—Telbivudine—hepatitis B	0.0119	0.0163	CcSEcCtD
Epoprostenol—Neck pain—Telbivudine—hepatitis B	0.0107	0.0146	CcSEcCtD
Epoprostenol—Musculoskeletal pain—Telbivudine—hepatitis B	0.0107	0.0146	CcSEcCtD
Epoprostenol—Hepatic failure—Entecavir—hepatitis B	0.0104	0.0142	CcSEcCtD
Epoprostenol—Influenza like illness—Telbivudine—hepatitis B	0.0103	0.014	CcSEcCtD
Epoprostenol—Hepatic failure—Adefovir Dipivoxil—hepatitis B	0.0101	0.0138	CcSEcCtD
Epoprostenol—Hypoxia—Lamivudine—hepatitis B	0.00938	0.0128	CcSEcCtD
Epoprostenol—PTGIR—blood—hepatitis B	0.00937	0.075	CbGeAlD
Epoprostenol—PTGIS—Eicosanoid Synthesis—GGT1—hepatitis B	0.0092	0.0651	CbGpPWpGaD
Epoprostenol—Sepsis—Telbivudine—hepatitis B	0.00917	0.0125	CcSEcCtD
Epoprostenol—CYP2C9—blood plasma—hepatitis B	0.00914	0.0732	CbGeAlD
Epoprostenol—Hyperaesthesia—Lamivudine—hepatitis B	0.00759	0.0103	CcSEcCtD
Epoprostenol—PTGIR—liver—hepatitis B	0.00732	0.0587	CbGeAlD
Epoprostenol—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00713	0.00971	CcSEcCtD
Epoprostenol—Haematuria—Entecavir—hepatitis B	0.00686	0.00936	CcSEcCtD
Epoprostenol—Gastritis—Telbivudine—hepatitis B	0.00679	0.00926	CcSEcCtD
Epoprostenol—Vasodilation procedure—Lamivudine—hepatitis B	0.00678	0.00924	CcSEcCtD
Epoprostenol—Vasodilation—Lamivudine—hepatitis B	0.00678	0.00924	CcSEcCtD
Epoprostenol—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0067	0.00913	CcSEcCtD
Epoprostenol—Abdominal distension—Telbivudine—hepatitis B	0.00668	0.0091	CcSEcCtD
Epoprostenol—Rectal haemorrhage—Lamivudine—hepatitis B	0.0066	0.00899	CcSEcCtD
Epoprostenol—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00659	0.00898	CcSEcCtD
Epoprostenol—Oedema peripheral—Entecavir—hepatitis B	0.00637	0.00868	CcSEcCtD
Epoprostenol—Abdominal discomfort—Telbivudine—hepatitis B	0.00636	0.00867	CcSEcCtD
Epoprostenol—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00626	0.00853	CcSEcCtD
Epoprostenol—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0062	0.00845	CcSEcCtD
Epoprostenol—Musculoskeletal pain—Lamivudine—hepatitis B	0.00603	0.00822	CcSEcCtD
Epoprostenol—PTGIS—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.00566	0.0401	CbGpPWpGaD
Epoprostenol—Mental disorder—Entecavir—hepatitis B	0.00566	0.00772	CcSEcCtD
Epoprostenol—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00541	0.00737	CcSEcCtD
Epoprostenol—Back pain—Adefovir Dipivoxil—hepatitis B	0.00531	0.00724	CcSEcCtD
Epoprostenol—Hypoaesthesia—Telbivudine—hepatitis B	0.00528	0.0072	CcSEcCtD
Epoprostenol—Pharyngitis—Telbivudine—hepatitis B	0.00527	0.00718	CcSEcCtD
Epoprostenol—Connective tissue disorder—Telbivudine—hepatitis B	0.00522	0.00711	CcSEcCtD
Epoprostenol—Sepsis—Lamivudine—hepatitis B	0.00517	0.00705	CcSEcCtD
Epoprostenol—PTGIS—Arachidonic acid metabolism—GGT1—hepatitis B	0.00512	0.0362	CbGpPWpGaD
Epoprostenol—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00507	0.00691	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—MIF—hepatitis B	0.00485	0.0343	CbGpPWpGaD
Epoprostenol—Cough—Adefovir Dipivoxil—hepatitis B	0.00479	0.00653	CcSEcCtD
Epoprostenol—Mediastinal disorder—Telbivudine—hepatitis B	0.00478	0.00652	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00476	0.00648	CcSEcCtD
Epoprostenol—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00467	0.00637	CcSEcCtD
Epoprostenol—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00467	0.00637	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00464	0.00633	CcSEcCtD
Epoprostenol—PTGIS—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00459	0.0325	CbGpPWpGaD
Epoprostenol—Anaphylactic shock—Entecavir—hepatitis B	0.00459	0.00626	CcSEcCtD
Epoprostenol—Infection—Entecavir—hepatitis B	0.00456	0.00622	CcSEcCtD
Epoprostenol—Thirst—Lamivudine—hepatitis B	0.00454	0.00619	CcSEcCtD
Epoprostenol—Nervous system disorder—Entecavir—hepatitis B	0.0045	0.00614	CcSEcCtD
Epoprostenol—Back pain—Telbivudine—hepatitis B	0.00447	0.00609	CcSEcCtD
Epoprostenol—Skin disorder—Entecavir—hepatitis B	0.00446	0.00608	CcSEcCtD
Epoprostenol—Muscle spasms—Telbivudine—hepatitis B	0.00444	0.00606	CcSEcCtD
Epoprostenol—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00439	0.00599	CcSEcCtD
Epoprostenol—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00439	0.00598	CcSEcCtD
Epoprostenol—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00435	0.00593	CcSEcCtD
Epoprostenol—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00427	0.00582	CcSEcCtD
Epoprostenol—Insomnia—Entecavir—hepatitis B	0.00415	0.00566	CcSEcCtD
Epoprostenol—Somnolence—Entecavir—hepatitis B	0.00408	0.00556	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00408	0.00556	CcSEcCtD
Epoprostenol—Dyspepsia—Entecavir—hepatitis B	0.00404	0.00551	CcSEcCtD
Epoprostenol—Cough—Telbivudine—hepatitis B	0.00403	0.0055	CcSEcCtD
Epoprostenol—PTGIS—Biological oxidations—GGT2—hepatitis B	0.00403	0.0285	CbGpPWpGaD
Epoprostenol—Gastrointestinal disorder—Entecavir—hepatitis B	0.00396	0.0054	CcSEcCtD
Epoprostenol—Fatigue—Entecavir—hepatitis B	0.00396	0.0054	CcSEcCtD
Epoprostenol—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00394	0.00537	CcSEcCtD
Epoprostenol—Myalgia—Telbivudine—hepatitis B	0.00393	0.00536	CcSEcCtD
Epoprostenol—Arthralgia—Telbivudine—hepatitis B	0.00393	0.00536	CcSEcCtD
Epoprostenol—Chest pain—Telbivudine—hepatitis B	0.00393	0.00536	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00391	0.00533	CcSEcCtD
Epoprostenol—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00389	0.00531	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00387	0.00527	CcSEcCtD
Epoprostenol—Abdominal distension—Lamivudine—hepatitis B	0.00376	0.00513	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Entecavir—hepatitis B	0.00375	0.00512	CcSEcCtD
Epoprostenol—Nervous system disorder—Telbivudine—hepatitis B	0.0037	0.00504	CcSEcCtD
Epoprostenol—Thrombocytopenia—Telbivudine—hepatitis B	0.00369	0.00503	CcSEcCtD
Epoprostenol—Skin disorder—Telbivudine—hepatitis B	0.00366	0.00499	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00366	0.00499	CcSEcCtD
Epoprostenol—Abdominal pain—Entecavir—hepatitis B	0.00363	0.00495	CcSEcCtD
Epoprostenol—Body temperature increased—Entecavir—hepatitis B	0.00363	0.00495	CcSEcCtD
Epoprostenol—Abdominal discomfort—Lamivudine—hepatitis B	0.00358	0.00488	CcSEcCtD
Epoprostenol—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00356	0.0251	CbGpPWpGaD
Epoprostenol—Pancytopenia—Lamivudine—hepatitis B	0.00355	0.00484	CcSEcCtD
Epoprostenol—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00354	0.00483	CcSEcCtD
Epoprostenol—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00354	0.00483	CcSEcCtD
Epoprostenol—PTGIS—Bile acid and bile salt metabolism—ALB—hepatitis B	0.00354	0.025	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00344	0.00468	CcSEcCtD
Epoprostenol—Insomnia—Telbivudine—hepatitis B	0.00341	0.00465	CcSEcCtD
Epoprostenol—Paraesthesia—Telbivudine—hepatitis B	0.00339	0.00462	CcSEcCtD
Epoprostenol—CYP2C9—blood—hepatitis B	0.00335	0.0268	CbGeAlD
Epoprostenol—Depression—Lamivudine—hepatitis B	0.00332	0.00453	CcSEcCtD
Epoprostenol—Dyspepsia—Telbivudine—hepatitis B	0.00332	0.00453	CcSEcCtD
Epoprostenol—Asthenia—Entecavir—hepatitis B	0.00329	0.00449	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00326	0.00444	CcSEcCtD
Epoprostenol—Fatigue—Telbivudine—hepatitis B	0.00325	0.00443	CcSEcCtD
Epoprostenol—Pain—Telbivudine—hepatitis B	0.00323	0.0044	CcSEcCtD
Epoprostenol—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00321	0.00438	CcSEcCtD
Epoprostenol—Sweating—Lamivudine—hepatitis B	0.0032	0.00435	CcSEcCtD
Epoprostenol—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00317	0.00432	CcSEcCtD
Epoprostenol—Epistaxis—Lamivudine—hepatitis B	0.00314	0.00428	CcSEcCtD
Epoprostenol—Diarrhoea—Entecavir—hepatitis B	0.00314	0.00428	CcSEcCtD
Epoprostenol—Sinusitis—Lamivudine—hepatitis B	0.00313	0.00426	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Telbivudine—hepatitis B	0.00308	0.0042	CcSEcCtD
Epoprostenol—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00307	0.00418	CcSEcCtD
Epoprostenol—Dizziness—Entecavir—hepatitis B	0.00304	0.00414	CcSEcCtD
Epoprostenol—Rhinitis—Lamivudine—hepatitis B	0.003	0.00409	CcSEcCtD
Epoprostenol—Abdominal pain—Telbivudine—hepatitis B	0.00298	0.00406	CcSEcCtD
Epoprostenol—Body temperature increased—Telbivudine—hepatitis B	0.00298	0.00406	CcSEcCtD
Epoprostenol—Hypoaesthesia—Lamivudine—hepatitis B	0.00298	0.00406	CcSEcCtD
Epoprostenol—Pharyngitis—Lamivudine—hepatitis B	0.00297	0.00405	CcSEcCtD
Epoprostenol—Connective tissue disorder—Lamivudine—hepatitis B	0.00294	0.00401	CcSEcCtD
Epoprostenol—Vomiting—Entecavir—hepatitis B	0.00292	0.00398	CcSEcCtD
Epoprostenol—Rash—Entecavir—hepatitis B	0.0029	0.00395	CcSEcCtD
Epoprostenol—Dermatitis—Entecavir—hepatitis B	0.00289	0.00394	CcSEcCtD
Epoprostenol—Headache—Entecavir—hepatitis B	0.00288	0.00392	CcSEcCtD
Epoprostenol—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00285	0.00388	CcSEcCtD
Epoprostenol—Rash—Adefovir Dipivoxil—hepatitis B	0.00282	0.00385	CcSEcCtD
Epoprostenol—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00282	0.00385	CcSEcCtD
Epoprostenol—Headache—Adefovir Dipivoxil—hepatitis B	0.00281	0.00383	CcSEcCtD
Epoprostenol—Nausea—Entecavir—hepatitis B	0.00273	0.00372	CcSEcCtD
Epoprostenol—Asthenia—Telbivudine—hepatitis B	0.00271	0.00369	CcSEcCtD
Epoprostenol—Mediastinal disorder—Lamivudine—hepatitis B	0.0027	0.00368	CcSEcCtD
Epoprostenol—Chills—Lamivudine—hepatitis B	0.00268	0.00366	CcSEcCtD
Epoprostenol—Pruritus—Telbivudine—hepatitis B	0.00267	0.00364	CcSEcCtD
Epoprostenol—Nausea—Adefovir Dipivoxil—hepatitis B	0.00266	0.00363	CcSEcCtD
Epoprostenol—CYP2C9—liver—hepatitis B	0.00262	0.021	CbGeAlD
Epoprostenol—Diarrhoea—Telbivudine—hepatitis B	0.00258	0.00352	CcSEcCtD
Epoprostenol—Flatulence—Lamivudine—hepatitis B	0.00257	0.0035	CcSEcCtD
Epoprostenol—Tension—Lamivudine—hepatitis B	0.00256	0.00348	CcSEcCtD
Epoprostenol—Nervousness—Lamivudine—hepatitis B	0.00253	0.00345	CcSEcCtD
Epoprostenol—Back pain—Lamivudine—hepatitis B	0.00252	0.00343	CcSEcCtD
Epoprostenol—Muscle spasms—Lamivudine—hepatitis B	0.0025	0.00341	CcSEcCtD
Epoprostenol—Dizziness—Telbivudine—hepatitis B	0.00249	0.0034	CcSEcCtD
Epoprostenol—Tremor—Lamivudine—hepatitis B	0.00244	0.00333	CcSEcCtD
Epoprostenol—PTGIS—Biological oxidations—CYP2A6—hepatitis B	0.00244	0.0172	CbGpPWpGaD
Epoprostenol—Anaemia—Lamivudine—hepatitis B	0.00241	0.00328	CcSEcCtD
Epoprostenol—Vomiting—Telbivudine—hepatitis B	0.0024	0.00327	CcSEcCtD
Epoprostenol—Rash—Telbivudine—hepatitis B	0.00238	0.00324	CcSEcCtD
Epoprostenol—Dermatitis—Telbivudine—hepatitis B	0.00238	0.00324	CcSEcCtD
Epoprostenol—Headache—Telbivudine—hepatitis B	0.00236	0.00322	CcSEcCtD
Epoprostenol—Syncope—Lamivudine—hepatitis B	0.00234	0.00318	CcSEcCtD
Epoprostenol—Loss of consciousness—Lamivudine—hepatitis B	0.00229	0.00312	CcSEcCtD
Epoprostenol—Cough—Lamivudine—hepatitis B	0.00227	0.0031	CcSEcCtD
Epoprostenol—Nausea—Telbivudine—hepatitis B	0.00224	0.00305	CcSEcCtD
Epoprostenol—Chest pain—Lamivudine—hepatitis B	0.00222	0.00302	CcSEcCtD
Epoprostenol—Myalgia—Lamivudine—hepatitis B	0.00222	0.00302	CcSEcCtD
Epoprostenol—Arthralgia—Lamivudine—hepatitis B	0.00222	0.00302	CcSEcCtD
Epoprostenol—Anxiety—Lamivudine—hepatitis B	0.00221	0.00301	CcSEcCtD
Epoprostenol—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.0022	0.0156	CbGpPWpGaD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.0022	0.003	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—HBE1—hepatitis B	0.00219	0.0155	CbGpPWpGaD
Epoprostenol—Dry mouth—Lamivudine—hepatitis B	0.00217	0.00296	CcSEcCtD
Epoprostenol—Confusional state—Lamivudine—hepatitis B	0.00214	0.00292	CcSEcCtD
Epoprostenol—Oedema—Lamivudine—hepatitis B	0.00213	0.0029	CcSEcCtD
Epoprostenol—Anaphylactic shock—Lamivudine—hepatitis B	0.00213	0.0029	CcSEcCtD
Epoprostenol—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00212	0.015	CbGpPWpGaD
Epoprostenol—Infection—Lamivudine—hepatitis B	0.00211	0.00288	CcSEcCtD
Epoprostenol—Shock—Lamivudine—hepatitis B	0.00209	0.00285	CcSEcCtD
Epoprostenol—Nervous system disorder—Lamivudine—hepatitis B	0.00208	0.00284	CcSEcCtD
Epoprostenol—Thrombocytopenia—Lamivudine—hepatitis B	0.00208	0.00284	CcSEcCtD
Epoprostenol—Skin disorder—Lamivudine—hepatitis B	0.00206	0.00281	CcSEcCtD
Epoprostenol—Hyperhidrosis—Lamivudine—hepatitis B	0.00205	0.0028	CcSEcCtD
Epoprostenol—Anorexia—Lamivudine—hepatitis B	0.00203	0.00276	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—HBE1—hepatitis B	0.00201	0.0142	CbGpPWpGaD
Epoprostenol—Hypotension—Lamivudine—hepatitis B	0.00199	0.00271	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00194	0.00264	CcSEcCtD
Epoprostenol—Insomnia—Lamivudine—hepatitis B	0.00192	0.00262	CcSEcCtD
Epoprostenol—Paraesthesia—Lamivudine—hepatitis B	0.00191	0.0026	CcSEcCtD
Epoprostenol—PTGIS—Biological oxidations—GGT1—hepatitis B	0.0019	0.0135	CbGpPWpGaD
Epoprostenol—Dyspnoea—Lamivudine—hepatitis B	0.0019	0.00258	CcSEcCtD
Epoprostenol—Somnolence—Lamivudine—hepatitis B	0.00189	0.00258	CcSEcCtD
Epoprostenol—Dyspepsia—Lamivudine—hepatitis B	0.00187	0.00255	CcSEcCtD
Epoprostenol—Decreased appetite—Lamivudine—hepatitis B	0.00185	0.00252	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00184	0.0025	CcSEcCtD
Epoprostenol—Fatigue—Lamivudine—hepatitis B	0.00183	0.0025	CcSEcCtD
Epoprostenol—Constipation—Lamivudine—hepatitis B	0.00182	0.00248	CcSEcCtD
Epoprostenol—Pain—Lamivudine—hepatitis B	0.00182	0.00248	CcSEcCtD
Epoprostenol—PTGIS—Adipogenesis—FAS—hepatitis B	0.00176	0.0125	CbGpPWpGaD
Epoprostenol—Gastrointestinal pain—Lamivudine—hepatitis B	0.00174	0.00237	CcSEcCtD
Epoprostenol—Urticaria—Lamivudine—hepatitis B	0.00169	0.0023	CcSEcCtD
Epoprostenol—Abdominal pain—Lamivudine—hepatitis B	0.00168	0.00229	CcSEcCtD
Epoprostenol—Body temperature increased—Lamivudine—hepatitis B	0.00168	0.00229	CcSEcCtD
Epoprostenol—PTGIR—Platelet homeostasis—NOS2—hepatitis B	0.00166	0.0117	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00161	0.0114	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Lamivudine—hepatitis B	0.00157	0.00213	CcSEcCtD
Epoprostenol—Asthenia—Lamivudine—hepatitis B	0.00153	0.00208	CcSEcCtD
Epoprostenol—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00151	0.0107	CbGpPWpGaD
Epoprostenol—Pruritus—Lamivudine—hepatitis B	0.0015	0.00205	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—HSPA5—hepatitis B	0.00147	0.0104	CbGpPWpGaD
Epoprostenol—Diarrhoea—Lamivudine—hepatitis B	0.00145	0.00198	CcSEcCtD
Epoprostenol—Dizziness—Lamivudine—hepatitis B	0.00141	0.00192	CcSEcCtD
Epoprostenol—Vomiting—Lamivudine—hepatitis B	0.00135	0.00184	CcSEcCtD
Epoprostenol—Rash—Lamivudine—hepatitis B	0.00134	0.00183	CcSEcCtD
Epoprostenol—Dermatitis—Lamivudine—hepatitis B	0.00134	0.00183	CcSEcCtD
Epoprostenol—Headache—Lamivudine—hepatitis B	0.00133	0.00181	CcSEcCtD
Epoprostenol—Nausea—Lamivudine—hepatitis B	0.00126	0.00172	CcSEcCtD
Epoprostenol—P2RY12—G alpha (i) signalling events—CXCL10—hepatitis B	0.00114	0.00803	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—CTNNB1—hepatitis B	0.000992	0.00701	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—CDKN1A—hepatitis B	0.000969	0.00685	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—SAG—hepatitis B	0.000948	0.00671	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—APOBEC3G—hepatitis B	0.000948	0.00671	CbGpPWpGaD
Epoprostenol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000915	0.00647	CbGpPWpGaD
Epoprostenol—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000903	0.00639	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000903	0.00639	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—CCR5—hepatitis B	0.000881	0.00623	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—F2—hepatitis B	0.000835	0.0059	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000831	0.00588	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL10—hepatitis B	0.000831	0.00588	CbGpPWpGaD
Epoprostenol—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000827	0.00585	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000817	0.00578	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—TGFB1—hepatitis B	0.000801	0.00567	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—F2—hepatitis B	0.000794	0.00561	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—HSPA5—hepatitis B	0.000757	0.00535	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000752	0.00532	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—hepatitis B	0.000752	0.00532	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—TNF—hepatitis B	0.000748	0.00529	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—F2—hepatitis B	0.000747	0.00528	CbGpPWpGaD
Epoprostenol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000742	0.00525	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000731	0.00517	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AKR1B1—hepatitis B	0.000718	0.00508	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.0007	0.00495	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—HSPA5—hepatitis B	0.000697	0.00493	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GGT2—hepatitis B	0.000688	0.00487	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CXCL10—hepatitis B	0.000688	0.00486	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IFNB1—hepatitis B	0.000683	0.00483	CbGpPWpGaD
Epoprostenol—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000669	0.00473	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IFNA1—hepatitis B	0.000666	0.00471	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—ALB—hepatitis B	0.000659	0.00466	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000651	0.0046	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000644	0.00456	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—hepatitis B	0.000644	0.00456	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCL10—hepatitis B	0.000633	0.00448	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCL10—hepatitis B	0.000633	0.00448	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IFNB1—hepatitis B	0.000628	0.00444	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IFNA2—hepatitis B	0.00062	0.00439	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IFNA1—hepatitis B	0.000613	0.00434	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—IL6—hepatitis B	0.000604	0.00427	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000601	0.00425	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IFNA2—hepatitis B	0.000571	0.00404	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000553	0.00391	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—F2—hepatitis B	0.000553	0.00391	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IL2—hepatitis B	0.000534	0.00378	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CCR5—hepatitis B	0.000533	0.00377	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RIT2—hepatitis B	0.000528	0.00373	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SAG—hepatitis B	0.000528	0.00373	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCR5—hepatitis B	0.000491	0.00347	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCR5—hepatitis B	0.000491	0.00347	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SAG—hepatitis B	0.000486	0.00344	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RIT2—hepatitis B	0.000486	0.00344	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RIT2—hepatitis B	0.000486	0.00344	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SAG—hepatitis B	0.000486	0.00344	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—F2—hepatitis B	0.000458	0.00324	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—GOT2—hepatitis B	0.00045	0.00319	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—F2—hepatitis B	0.000421	0.00298	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—F2—hepatitis B	0.000421	0.00298	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—CYP2A6—hepatitis B	0.000417	0.00295	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—TGFB1—hepatitis B	0.000417	0.00295	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—F2—hepatitis B	0.000409	0.00289	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—NOS2—hepatitis B	0.000404	0.00286	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.000394	0.00279	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000389	0.00275	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—GOT1—hepatitis B	0.000389	0.00275	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL10—hepatitis B	0.000389	0.00275	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GOT2—hepatitis B	0.000377	0.00267	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—F2—hepatitis B	0.000377	0.00266	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—NOS2—hepatitis B	0.000372	0.00263	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL10—hepatitis B	0.000358	0.00253	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL10—hepatitis B	0.000358	0.00253	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL10—hepatitis B	0.000353	0.0025	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—ALB—hepatitis B	0.00034	0.0024	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GOT1—hepatitis B	0.000326	0.0023	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GGT1—hepatitis B	0.000326	0.0023	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL10—hepatitis B	0.000325	0.0023	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL10—hepatitis B	0.000325	0.0023	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—ALB—hepatitis B	0.000313	0.00221	CbGpPWpGaD
Epoprostenol—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000308	0.00218	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CCR5—hepatitis B	0.000301	0.00213	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000297	0.0021	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hepatitis B	0.000296	0.00209	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CCR5—hepatitis B	0.00029	0.00205	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—HLA-A—hepatitis B	0.000283	0.002	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CCR5—hepatitis B	0.000277	0.00196	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCR5—hepatitis B	0.000277	0.00196	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IL2—hepatitis B	0.000276	0.00195	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCR5—hepatitis B	0.000274	0.00194	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000261	0.00184	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—F2—hepatitis B	0.000259	0.00183	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL2—hepatitis B	0.000254	0.00179	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCR5—hepatitis B	0.000252	0.00178	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCR5—hepatitis B	0.000252	0.00178	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—NOS2—hepatitis B	0.000246	0.00174	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—F2—hepatitis B	0.000238	0.00168	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—F2—hepatitis B	0.000238	0.00168	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—F2—hepatitis B	0.000235	0.00166	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—F2—hepatitis B	0.000216	0.00153	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—F2—hepatitis B	0.000216	0.00153	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TGFB1—hepatitis B	0.000215	0.00152	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL10—hepatitis B	0.000208	0.00147	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TGFB1—hepatitis B	0.000198	0.0014	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL10—hepatitis B	0.000192	0.00136	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL10—hepatitis B	0.000192	0.00136	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD4—hepatitis B	0.000182	0.00129	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—TP53—hepatitis B	0.000177	0.00125	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—hepatitis B	0.000174	0.00123	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ALB—hepatitis B	0.000173	0.00122	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—TP53—hepatitis B	0.000163	0.00115	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CTNNB1—hepatitis B	0.000162	0.00114	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCR5—hepatitis B	0.000162	0.00114	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—hepatitis B	0.00016	0.00113	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—hepatitis B	0.00016	0.00113	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CDKN1A—hepatitis B	0.000158	0.00112	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—hepatitis B	0.000158	0.00112	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PTEN—hepatitis B	0.000158	0.00112	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR5—hepatitis B	0.000149	0.00105	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR5—hepatitis B	0.000149	0.00105	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—hepatitis B	0.000146	0.00103	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—hepatitis B	0.000146	0.00103	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—F2—hepatitis B	0.000139	0.000981	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PTEN—hepatitis B	0.000132	0.000935	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—hepatitis B	0.000131	0.000925	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—F2—hepatitis B	0.000128	0.000903	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—F2—hepatitis B	0.000128	0.000903	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000118	0.000836	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKR1B1—hepatitis B	0.000116	0.000821	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GGT2—hepatitis B	0.000111	0.000787	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—hepatitis B	9.86e-05	0.000697	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—hepatitis B	9.34e-05	0.000661	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—hepatitis B	9.29e-05	0.000657	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CTNNB1—hepatitis B	9.02e-05	0.000638	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CDKN1A—hepatitis B	8.81e-05	0.000623	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PTEN—hepatitis B	8.79e-05	0.000622	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NFKB1—hepatitis B	8.75e-05	0.000619	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—hepatitis B	8.6e-05	0.000608	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—hepatitis B	8.6e-05	0.000608	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—hepatitis B	8.55e-05	0.000605	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—hepatitis B	8.55e-05	0.000605	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CTNNB1—hepatitis B	8.3e-05	0.000587	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CTNNB1—hepatitis B	8.3e-05	0.000587	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CDKN1A—hepatitis B	8.11e-05	0.000573	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CDKN1A—hepatitis B	8.11e-05	0.000573	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PTEN—hepatitis B	8.09e-05	0.000572	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PTEN—hepatitis B	8.09e-05	0.000572	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NFKB1—hepatitis B	8.05e-05	0.000569	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NFKB1—hepatitis B	8.05e-05	0.000569	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—hepatitis B	7.29e-05	0.000515	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2A6—hepatitis B	6.74e-05	0.000477	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—hepatitis B	6.71e-05	0.000474	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—hepatitis B	6.71e-05	0.000474	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	6.28e-05	0.000444	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GOT2—hepatitis B	6.1e-05	0.000431	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TP53—hepatitis B	6e-05	0.000424	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TP53—hepatitis B	5.52e-05	0.00039	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TP53—hepatitis B	5.52e-05	0.00039	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—hepatitis B	5.49e-05	0.000388	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GOT1—hepatitis B	5.26e-05	0.000372	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GGT1—hepatitis B	5.26e-05	0.000372	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—hepatitis B	5.05e-05	0.000357	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—hepatitis B	5.05e-05	0.000357	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.79e-05	0.000339	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—hepatitis B	2.8e-05	0.000198	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTEN—hepatitis B	2.14e-05	0.000151	CbGpPWpGaD
